510(k) Report

510(k) · Cleared

Cleared

Alma FemiLift Pixel CO2 Laser System, Delivery Devices and Accessories

K250071510(k) TraditionalCleared Sep 24, 2025257-day reviewClass II21 CFR 878.4810

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Alma Lasers, Inc. · GEX Powered Laser Surgical Instrument

Cleared on Sep 24, 2025 as substantially equivalent to K103501 (Alma Lasers, Inc., 2011) after a 257-day review. Its family tree reaches back 9 generations to 1994.

Decided
Sep 24, 2025
Review
257 days
Class
Class II
Product code
GEX
Recalls
None
Predicates
1

Its longest line of descent runs back 9 generations to K936109 (1994). 30 ancestors in all, the oldest K822136 (1982). No later device cites it as a predicate yet.

  1. Root · 9 generations backK936109 Sharplan Model 1120 CO2 Surgical LaserSharplan Lasers, Inc. · 1994
  2. 5 generations between
  3. 3 generations backK040234 Laserpro CO2 Carbon Dioxide Laser SystemPhoto Medex, Inc. · 2004
  4. 2 generations backK080463 Alma Lasers Thermoxel CO2 Laser System and Delivery Device AccessoriesAlma Lasers, Ltd. · 2008
  5. 1 generation backK103501 Alma Lasers Pixel CO2 Laser System, Delivery Device and AccessoriesAlma Lasers, Inc. · 2011
  6. This deviceK250071 Alma FemiLift Pixel CO2 Laser System, Delivery Devices and AccessoriesAlma Lasers, Inc. · 2025
Show all 9 generations
  1. Root · 9 generations backK936109 Sharplan Model 1120 CO2 Surgical LaserSharplan Lasers, Inc. · 1994
  2. 8 generations backK960521 Sharplan Lasers, Inc. Silktouch Flash ScannerSharplan Lasers, Inc. · 1996
  3. 7 generations backK963339 Coherent Ultrapulse CO2 Surgical LasersCoherent Medical Group · 1997
  4. 6 generations backK974789 Coherent Ultrapulse S Series CO2 Surgical Lasers Model C and LLumenis, Inc. · 1998
  5. 5 generations backK022060 Lumenis Ultrapulse Encore Carbon Dioxide Surgical Lasers and…Lumenis, Inc. · 2002
  6. 4 generations backK030147 Lumenis Family of Ultrapulse Surgitouch CO2 Surgical LasersLumenis, Ltd. · 2003
  7. 3 generations backK040234 Laserpro CO2 Carbon Dioxide Laser SystemPhoto Medex, Inc. · 2004
  8. 2 generations backK080463 Alma Lasers Thermoxel CO2 Laser System and Delivery Device AccessoriesAlma Lasers, Ltd. · 2008
  9. 1 generation backK103501 Alma Lasers Pixel CO2 Laser System, Delivery Device and AccessoriesAlma Lasers, Inc. · 2011
  10. This deviceK250071 Alma FemiLift Pixel CO2 Laser System, Delivery Devices and AccessoriesAlma Lasers, Inc. · 2025
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−9K936109Sharplan Model 1120 CO2 Surgical LaserSharplan Lasers, Inc.1994—
−8K960521Sharplan Lasers, Inc. Silktouch Flash ScannerSharplan Lasers, Inc.1996—
−7K963339Coherent Ultrapulse CO2 Surgical LasersCoherent Medical Group1997—
−6K974789Coherent Ultrapulse S Series CO2 Surgical Lasers Model C and LLumenis, Inc.1998—
−5K022060Lumenis Ultrapulse Encore Carbon Dioxide Surgical Lasers and Delivery Device…Lumenis, Inc.2002—
−4K030147Lumenis Family of Ultrapulse Surgitouch CO2 Surgical LasersLumenis, Ltd.2003—
−3K040234Laserpro CO2 Carbon Dioxide Laser SystemPhoto Medex, Inc.2004—
−2K080463Alma Lasers Thermoxel CO2 Laser System and Delivery Device AccessoriesAlma Lasers, Ltd.2008—
−1K103501Alma Lasers Pixel CO2 Laser System, Delivery Device and AccessoriesAlma Lasers, Inc.2011—
0 (this device)K250071Alma FemiLift Pixel CO2 Laser System, Delivery Devices and AccessoriesAlma Lasers, Inc.2025—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198210
198610
198810
199010
199110
199440
199550
199630
199810
199920
200710
FIG. 1 — Lineage of K250071, 1994–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GEX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GEX device

  1. #1 K222064 The Alma Soprano Titaniumscore 38.1 · 24 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K103501Alma Lasers Pixel CO2 Laser System, Delivery Device and Accessories
Summary page 9
…Classification Regulation: 21 CFR 878.4810 Product Code: GEX Predicate Device Alma Lasers Pixel CO2 Laser System, Delivery Device and Accessories (K103501) Device Description The Alma FemiLift Pixel CO2 System is a laser system designed to deliver light energy for use i…
Alma Lasers, Inc.2011—

Also cleared against K103501: 4 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 31 years and passes through 7 companies; a new generation was cleared every 1.9 years on median.
  • None of the 30 ancestors has a recall.
  • 4 other devices also cite its predicate K103501.

How does its category compare?

All GEX devices

GEX Powered Laser Surgical Instrument: FDA decisions, review times, recalls and adverse event reports over 20 years. 2025, this device’s year, is highlighted.

FDA decisions per year · GEX

83in 2025

2007: 732008: 1072009: 692010: 502011: 412012: 452013: 462014: 612015: 472016: 512017: 672018: 512019: 412020: 522021: 532022: 602023: 522024: 822025: 832026 (partial year): 57
2007high 107 (2008) · low 41 (2011)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GEX

90in 2025

2007: 79 days median2008: 86 days median2009: 100 days median2010: 96 days median2011: 83 days median2012: 118 days median2013: 144 days median2014: 147 days median2015: 112 days median2016: 114 days median2017: 90 days median2018: 78 days median2019: 88 days median2020: 90 days median2021: 123 days median2022: 152 days median2023: 87 days median2024: 90 days median2025: 90 days median2026 (partial year): 90 days median
2007high 152 (2022) · low 78 (2018)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GEX

3in 2024

2007: 92008: 22010: 42011: 182012: 52013: 32014: 62016: 12017: 5, 1 Class I2018: 52019: 62020: 12023: 62024: 32026 (partial year): 2
2007high 18 (2011) · low 0 (2009)2026

Class I (1 since 2007) Class II/III not classified

Adverse event reports per year · GEX

2,720in 2025

2007: 3422008: 2322009: 2092010: 1,7112011: 3,0242012: 2,0002013: 2,2362014: 2,0362015: 2,0992016: 2,5852017: 2,9772018: 3,5252019: 2,7092020: 2,1832021: 3,4652022: 2,2882023: 2,3372024: 2,1872025: 2,720
2007high 3,525 (2018) · low 209 (2009)2025

MAUDE reports naming product code GEX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200773799342
2008107862232
2009691000209
2010509641,711
20114183183,024
20124511852,000
20134614432,236
20146114762,036
20154711202,099
20165111412,585
201767905 (1)2,977
2018517853,525
2019418862,709
2020529012,183
20215312303,465
20226015202,288
2023528762,337
2024829032,187
2025839002,720
202657902—

What is it indicated for?

The Alma FemiLift Pixel CO2 Laser System and Delivery Device Accessories are intended for use in surgical applications requiring the ablation, vaporization, excision, incision, and coagulation of soft tissue in medical specialties including: aesthetic surgery (dermatology and plastic surgery), podiatry, gynecology, neurosurgery, orthopedics (soft tissue), arthroscopy (knee).The Alma FemiLift Pixel CO2 Laser System is cleared for use for the particular…

Read the full statement (1,228 words)

The Alma FemiLift Pixel CO2 Laser System and Delivery Device Accessories are intended for use in surgical applications requiring the ablation, vaporization, excision, incision, and coagulation of soft tissue in medical specialties including: aesthetic surgery (dermatology and plastic surgery), podiatry, gynecology, neurosurgery, orthopedics (soft tissue), arthroscopy (knee).The Alma FemiLift Pixel CO2 Laser System is cleared for use for the particular indications as follows:

Dermatology & Plastic Surgery

The ablation, vaporization, excision, incision, and coagulation of soft tissue in dermatology and plastic surgery in the performance of:

• Laser skin resurfacing

• Laser dermabrasion

• Laser burn debridement.

Laser skin resurfacing (ablation and/or vaporization) for the treatment of:

• Wrinkles, rhytids, and furrows (including fines lines and texture irregularities)

Clinical literature demonstrates that skin resurfacing of wrinkles, rhytids, and furrows with CO2 laser increases the amount of sub-epidermal collagen.

Laser skin resurfacing (ablation and/or vaporization) of soft tissue for the reduction, removal, and/or treatment of:

• Keratoses, including actinic and seborrheic keratosis, seborrheic vulgaris, seborrheic wart, and verruca seborrhoica;

• Vermilionectomy of the lip;

• Cutaneous horns;

• Solar/actinic elastosis;

• Cheilitis, including actinic cheilitis;

• Lentigines, including lentigo maligna or Hutchinson’s malignant freckle;

• Uneven pigmentation/ dyschromia;

• Acne scars;

• Surgical scars;

• Keloids including acne keloidalis nuchae;

• Hemangiomas (including Buccal, port wine and pyogenic granulomas/granuloma pyogenicum/granuloma telagiectaticum);

• Tattoos;

• Telangiectasia;

• Removal of small skin tumors, including periungual (Koenen) and subungual fibromas;

• Superficial pigmented lesions;

• Aden sebaceous hypertrophy or sebaceous hyperplasia;

• Rhinophyma reduction;

• Cutaneous papilloma (skin tags);

• Milia;

• Debridement of eczematous or infected skin;

• Basal and squamous cell carcinoma, including keratoacanthomas, Bowen's disease (Erythroplasia of Queyrat), and Bowenoid Papulosis (BP) lesions;

• Nevi, including spider, epidermal and protruding;

• Neurofibromas;

• Laser de-epithelialization;

• Trichoepitheliomas;

• Xanthelasma Palpebrarum;

• Syringoma

Laser ablation, vaporization and /or excision for complete or partial nail matrixectomy.

Vaporization/coagulation of:

• Benign/malignant vascular/avascular skin lesions;

• Moh’s Surgery;

• Lipectomy;

• Verrucae and seborrheic vulgaris, including paronychial, perifungal, and subungual warts.

Laser incision and /or excision of soft tissue for the performance of upper and lower eyelid blepharoplasty.

Laser incision and /or excision of soft tissue for the creation of recipient sites for hair transplantation.

Laser incision and /or excision of soft tissue for the performance of upper and lower eyelid blepharoplasty.

Laser incision and /or excision of soft tissue for the creation of recipient sites for hair transplantation.

Podiatry

Laser ablation, vaporization and /or excision of soft tissue for the reduction, removal, and/or treatment of:

• Verrucae vulgaris/plantar (warts), including paronychial, perifungal, and subungual warts;

• Fungal nail treatment;

• Porokeratoma ablation;

• Ingrown nail treatment;

• Neuromas/fibromas, including Morton's neuroma;

• Debridement of ulcers;

• Other soft tissue lesions.

Laser ablation, vaporization and /or excision in podiatry for complete or partial matrixectomy.

Otolaryngology (ENT)

Laser incision, excision, ablation and/or vaporization of soft tissue in otolaryngology the treatment of:

• Choanal atresia,

• Leukoplakia, including oral, larynx, uvula, palatal, upper lateral pharyngeal tissue;

• Nasal obstruction;

• Adult and juvenile papillomatosis polyps;

• Polypectomy of nose and nasal passages;

• Lymphangioma removal;

• Removal of vocal cord/fold nodules, polyps and cysts;

• Removal of recurrent papillomas in the oral cavity, nasal cavity, larynx, pharynx and trachea, including the uvula, palatal, upper lateral pharyngeal tissue, tongue and vocal cords;

• Laser/tumor surgery in the larynx, pharynx, nasal, ear and oral structure and tissue

• Zenker’s Diverticulum/pharyngoesophageal diverticulum [endoscopic laser-assisted esophageal diverticulectomy (ELAED)];

• Stenosis, including subglottic stenosis; tonsillectomy (including tonsillar cryptolysis, neoplasma) and tonsil ablation/tonsillotomy;

• Pulmonary bronchial and tracheal lesion removal;

• Benign and malignant nodules, tumors and fibromas (larynx, pharynx, trachea, tracheobronchial/endobronchial);

• Benign and malignant lesions and fibromas (nose and nasal passages);

• Benign and malignant tumors and fibromas; (oral);

• Stapedotomy/stapedectomy;

• Acoustic neuroma in the ear;

• Superficial lesions of the ear, including chondrodermatitis nondularis chronica helices/Winkler’s disease;

• Telangiectasia/hemangioma of larynx, pharynx and trachea (includes uvula, palatal or upper lateral pharyngeal tissue);

• Cordectomy, cordotomy (for the treatment of vocal fold paralysis/vocal fold motion impairment), and cordal lesions of larynx, pharynx and trachea;

• Myringotomy/tympanostomy (tympanic membrane fenestration);

• Uvulopalatoplasty (LAUP, laser UPPP);

• Turbinectomy and turbinate reduction/ablation);

• Septal spur ablation/reduction and septoplasty;

• Partial glossectomy;

• Tumor resection on oral, subfascial and neck tissues;

• Rhinophyma;

• Verrucae vulgaris (warts);

• Gingivoplasty/gingivectomy.

Gynecology (GYN)

Laser incision, excision, ablation and/or vaporization and of soft tissue in gynecology (GYN) for the treatment of:

• Conization of the cervix, including cervical intraepithelial neoplasia (CIN), vulvar and vaginal intraepithelial neoplasia (VIN, VAIN);

• Condyloma acuminate, including cervical, genital, vulvar, perineal, and Bowen’s disease, (Erythroplasia of Queyrat) and Bowenoid papulosis (BP) lesions;

• Leukoplakia (vulvar dystrophies);

• Incision and drainage (I&D) of Bartholin’s and Nabothian cysts;

• Herpes vaporization;

• Urethral caruncle vaporization;

• Cervical dysplasia;

• Benign and malignant tumors;

• Hemangiomas.

GYN Laparoscopy

Vaporization, incision, excision, ablation, or photocoagulation of soft tissue in endoscopic and laparoscopic surgery, including GYN laparoscopy, for treatment of:

• Endometrial lesions, including ablation of endometriosis;

• Excision/lysis of adhesions;

• Salpingostomy

• Oophorectomy/ovariectomy;

• Fimbrioplasty;

• Metroplasty;

• Microsurgery (tubal);

• Uterine myomas and fibroids;

• Ovarian fibromas and follicle cysts;

• Uterosacral ligament ablation;

• Hysterectomy.

Neurosurgery

Laser incision, excision, ablation and/or vaporization and of soft tissue in neurosurgery for the treatment of:

Cranial

• Posterior fossa tumors;

• Peripheral neurectomy;

• Benign and malignant tumors and cysts (e.g. gliomas, meningiomas (including basal tumors), acoustic neuromas, lipomas and large tumors);

• Arteriovenous malformation;

• Pituitary gland tumors (transsphenoidal approach).

Spinal Cord

• Incision/excision and vaporization of benign and malignant tumors and cysts;

• Intra- and extradural lesions;

• Laminectomy/ laminotomy/ microdiscectomy.

Orthopedics

Incision/excision and vaporization and of soft tissue in orthopedic surgery. Applications include:

Arthroscopy

• Meniscectomy;

• Chondromalacia;

• Chondroplasty;

• Ligament release (lateral and other);

• Excision of plica;

• Partial synovectomy.

General

• Debridement of traumatic wounds;

• Debridement of decubitus and diabetic ulcers;

• Microsurgery;

• Artificial joint revision;

• PMMA removal.

General/Thoracic Surgery

Incision, excision and vaporization and of soft tissue in general and thoracic surgery including endoscopic and open procedures. Applications include:

• Debridement of decubitus ulcers, stasis, diabetic and other ulcers;

• Mastectomy;

• Debridement of burns;

• Rectal and anal hemorrhoidectomy;

• Breast biopsy;

• Reduction mammoplasty;

• Cytoreduction for metastatic disease;

• Laparotomy and laparoscopic applications;

• Mediastinal and thoracic lesions and abnormalities;

• Skin tag vaporization;

• Atheroma;

• Cysts, including sebaceous cysts, pilar cysts, and mucous cysts of the lips;

• Pilonidal cyst removal and repair;

• Abscesses;

• Other soft tissue applications.

Dental/Oral Surgery

Incision/excision and vaporization of soft tissue in dentistry and oral surgery. Applications include:

• Gingivectomy- removal of hyperplasia;

• Gingivoplasty;

• Incisional and excisional biopsy;

• Treatment of ulcerous lesions, including aphthous ulcers;

• Incision of infection when used with antibiotic therapy;

• Frenectomy (frenum release);

• Excision and ablation of benign and malignant lesions;

• Homeostasis;

• Operculectomy;

• Crown lengthening;

• Removal of soft tissue, cysts and tumors;

• Oral cavity tumors and hemangiomas;

• Abscesses;

• Extraction site hemostasis;

• Salivary gland pathologies;

• Pre-prosthetic gum preparation;

• Leukoplakia;

• Partial glossectomy;

• Periodontal gum resection.

Genitourinary

Incision/excision and vaporization and of soft tissue in genitourinary procedures. Applications include:

• Benign and malignant lesions of external genitalia;

• Condyloma;

• Phimosis

• Erythroplasia

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K250071: Alma FemiLift Pixel CO2 Laser System, Delivery Devices and Accessories.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K250071

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026